MATERNAL SERUM ALPHA-FETOPROTEIN AND HUMAN CHORIONIC-GONADOTROPIN IN PREGNANT-WOMEN WITH ACUTE PARVOVIRUS B19 INFECTION WITH AND WITHOUT FETAL COMPLICATIONS
K. Komischke et al., MATERNAL SERUM ALPHA-FETOPROTEIN AND HUMAN CHORIONIC-GONADOTROPIN IN PREGNANT-WOMEN WITH ACUTE PARVOVIRUS B19 INFECTION WITH AND WITHOUT FETAL COMPLICATIONS, Prenatal diagnosis, 17(11), 1997, pp. 1039-1046
Maternal serum alpha-fetoprotein (MS-AFP) and human gonadotropin (MS-h
CG) were retrospectively determined in 137 sera from 65 pregnant women
with an acute parvovirus B19 infection. In 35 of the pregnant women,
fetal complications occurred (group 1); in the remaining 30 women, the
re were no fetal complications (group 2). In group 1, significant elev
ations of MS-AFP were detected in 13 of the 35 women (37 per cent) and
of MS-hCG in 25 of the 35 women (71 per cent). In nine of those women
, sera were obtained before occurrence of fetal complications and MS-A
FP was elevated in one case and MS-hCG in four cases. In one woman, bo
th MS-AFP and MS-hCG were elevated. In group 2, significant elevations
of MS-AFP were found in two of the 30 women (6.7 per cent) and of MS-
hCG in five of the 30 women (16.7 per cent). Neither MS-AFP nor MS-hCG
appears to be a regular early marker for poor pregnancy outcome in pa
rvovirus B19-infected pregnancies, although they were frequently eleva
ted at the time of complications. (C) 1997 by John Wiley & Sons, Ltd.